Am J Perinatol 2009; 26(2): 135-137
DOI: 10.1055/s-0028-1091399
© Thieme Medical Publishers

Ultrasound Findings in Trisomy 22

Wade D. Schwendemann1 , Stephen A. Contag2 , Patrick P. Koty2 , Richard C. Miller3 , Patricia Devers4 , William J. Watson1
  • 1Mayo Clinic College of Medicine, Rochester, Minnesota
  • 2Wake Forest Medical Center, Maternal-Fetal Medicine, Winston-Salem, North Carolina
  • 3Saint Barnabas Medical Center, Livingston, New Jersey
  • 4Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
10. Oktober 2008 (online)

ABSTRACT

We sought to identify the characteristic sonographic findings of fetal trisomy 22 by performing a retrospective review of nine cases of fetal trisomy 22. All cases of chromosomal mosaicism were excluded, as were first-trimester losses. Indications for sonography, gestational age, and sonographically detected fetal anomalies were analyzed. The majority of patients were referred for advanced maternal age or abnormal ultrasound findings on screening exam. Oligohydramnios was the most common sonographic finding, present in 55% of affected fetuses. Intrauterine growth restriction and increased nuchal thickness were slightly less frequent.

REFERENCES

  • 1 Hassold T, Chen N, Funkhouser J et al.. A cytogenetic study of 1000 spontaneous abortions.  Ann Hum Genet. 1980;  44 151-178
  • 2 Stressig R, Kortge-Jung S, Hickman G, Kozlowski P. Prenatal sonographic findings in trisomy 22.  J Ultrasound Med. 2005;  24 1547-1553
  • 3 Sepulveda W, Cecilia B, Schnapp C et al.. Second-trimester sonographic in trisomy 22.  J Ultrasound Med. 2003;  22 1271-1275
  • 4 Bacino C A, Schreck R, Rischel-Ghodsian N et al.. Clinical and molecular studies in full trisomy 22.  Am J Med Genet. 1995;  56 359-365
  • 5 Hengstschläger M, Bettelheim D, Rosner M et al.. Extended prenatal survival of a non-mosaic trisomy 22 with aneuploid cytotrophoblasts.  Prenat Diagn. 2001;  21 897-899
  • 6 Harding K, Freeman J, Weston W, Smith J R. Trisomy 22: prenatal diagnosis, a case report.  Ultrasound Obstet Gynecol. 1995;  5 136-137
  • 7 Mokate T, Leask K, Mehta S et al.. Non-mosaic trisomy 22: a report of 2 cases.  Prenat Diagn. 2006;  26 962-965
  • 8 Tinkle B T, Walker M E, Blough-Pfau R I et al.. Unexpected survival in a case of prenatally diagnosed non-mosaic trisomy 22: clinical report and review of the natural history.  Am J Med Genet A. 2003;  118A 90-95
  • 9 Bergeron M B, Tran-Thanh D, Fournet J C et al.. Male pseudohermaphroditism and gonadal mosaicism in a 47, XY, + 22 fetus.  Am J Med Genet A. 2006;  140 1768-1772
  • 10 Snijders R J, Nicolaides K H. Fetal biometry at 14–40 weeks' gestation.  Ultrasound Obstet Gynecol. 1994;  4 34-48
  • 11 Deter R L, Harrist R B, Hadlock F P, Poindexter A N. Longitudinal studies of fetal growth with the use of dynamic image ultrasonography.  Am J Obstet Gynecol. 1982;  143 545-554
  • 12 Hoskins I A, McGovern P G, Ordorica S A, Frieden F J, Young B K. Amniotic fluid index: correlation with amniotic fluid volume.  Am J Perinatol. 1992;  9 315-318
  • 13 Herman A, Dreazen E, Herman A M, Batukan C E, Holzgreve W, Tercanli S. Bedside estimation of Down syndrome risk during first-trimester ultrasound screening.  Ultrasound Obstet Gynecol. 2002;  20 468-475

Wade D SchwendemannM.D. 

Mayo Clinic College of Medicine

200 First Street, SW, Rochester, MN, 55905

eMail: schwendemann.wade@mayo.edu

    >